Research
And Grants
Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.
Submit Grant ApplicationNote: All Grants Are U.S. Funded Through 2018
Cincinnati Children's Hospital – $200,000
$200,000.00
September 2021
Targeting Purine Synthesis and One Carbon Metabolism in DIPG
UPMC Children's Hospital – $50,000
$50,000.00
September 2021
The Role of QPRT and NAD Pathways in DIPG Treatment Resistance
University of Queensland Diamantina Institute – $100,000
$100,000.00
September 2021
Innovative Models of the Brain Microenvironment to Identify New Treatments for Medulloblastoma
Duke University Hospital – $50,000
$50,000.00
September 2021
Identifying Oncolytic Viral Therapy Resistance Mechanisms in Brain Tumors
Funding of PBTCF 2021: PBTC-059 - $25,000
$25,000.00
January 2021
Phase 1 Trial of Autologous HER2-specific CAR T cells in Pediatric Patients with Refractory or Recurrent Ependymoma
International DIPG/DMG Registry And Repository - $1,508,198
$1,508,198.00
December 2020
Children's Cancer Institute - $99,251
$99,251.00
September 2020
Discovering New Epigenetic Players in DIPG Oncogenesis
Northwestern Memorial Hospital - $110,000
$110,000.00
September 2020
Development of Histone Demethylase Inhibitor Against DIPG
The Hospital for Sick Children - $100,000
$100,000.00
September 2020
Methionne Deptrivation as a Therapeutic Strategy for Diffuse Intrinsic Pontine Glioma
Hunter Medical Research Institute - $145,640
$145,640.00
September 2020
Combatt DMG: Combined Anti-tumor Targeting of Diffuse Midline Gliomas
CONNECT Consortium - $489,801.26
$489,801.00
September 2020
CONNECT (COllaborative Network for NEurooncology Clinical Trials) Consortium
International DIPG/DMG Registry And Repository - $862,671
$862,671.00
May 2020
Funding of PBTCF 2020: PBTC-058 - $25,000
$25,000.00
January 2020
PBTC-058: Phase 2 Study of Intraventricular Omburtamab-based Radioimmunotherapy for Pediatric Patients with Recurrent Medulloblastoma and Ependymoma
Sydney Children's Hospital - $151,468
$151,468.00
December 2019
Developing New Epigenetic Combination Treatments Against DIPG.
Oncoceutics ONC201 - $100,000
$100,000.00
December 2019
Expansion of the ONC201 Compassionate Use.